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Abstract  
Cardiovascular diseases (CVD) often share similar risk factors, and are presently a leading cause of 
death in South Africa and sub-Sahara Africa. Hypertension (HT) remains the commonest risk factor 
for strokes and heart attacks. There are several behavioural and environmental contributory factors to 
the development of HT. In an effort to lessen worldwide prevalence of HT, global strategies have 
focused on the reduction of salt/sodium (Na
+
) intake as a means of lowering BP in populations. In 
the present study I first validated the 24-hour urine collection method by comparing a one day 24-
hour urine sample with six consecutive day 24-hour urine samples and then evaluated the 
relationship between dietary Na
+
 intake and blood pressure (BP) in 629 South Africans of African 
ancestry. All participants had complete conventional BP measurements, 489 had complete 
ambulatory BP measurements, and 597 had complete urine collection. The mean age of the 
participants was 43.9±18.4. The average body mass index (BMI) of the population sample was 
29.2±7.9. 37.1% were hypertensive, 23.0% regularly consumed alcohol, 16.9% were tobacco 
smokers, and 12.2% had diabetes mellitus. The average 24-hour urinary Na
+
 excretion rate was 111.2 
mmol/day, and K
+
 excretion rates were 28.9 mmol/day. There was no significant difference between 
the one day urine collection and the subsequent six day collection in terms of Na
+
 and K
+
 excretion. 
The averages were 109.2 mmol/day and 113.2mmol/day respectively. The Bland-Augment curve 
showed a bias of -2.4 which is clinically insignificant, suggesting that the two procedures are similar.  
After correcting for covariates, there was no significant relationship between Na
+
 intake and 
conventional BP {SBP (P=0.49), DBP (P=0.95)}, ambulatory BP {24-hour SBP (P=0.17), DBP 
(P=0.59); daytime SBP (P=0.15), DBP (P=0.68); night-time SBP (P=0.69), DBP (P=0.25)}. Even 
when participants were grouped according to age, there was no significant increase in BP in 
participants whose daily sodium intake was above the threshold of 100mmol/day when compared to 
participants with normal sodium intake. However there was strong relationship between BP and 
Na
+
/K
+
. A multivariate data analysis revealed a strong inverse relationship between urinary Na
+
 and 
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age (P≤0.001). Plasma renin was related to BP (P=0.0001). In conclusion, the present study has 
demonstrated that in a randomly recruited urban community sample of African ancestry, a single 24-
hour urine measurement is sufficient to estimate the levels of Na
+
 intake. There is no relationship 
between both Na
+ 
and K
+ 
with BP. However there is a strong association between BP and the 
sodium-to-potassium ratio indicating that, in this population, the interaction between sodium and 
potassium ions plays a more important role in the regulation of BP than K
+ 
and Na
+ 
alone.   
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Preface  
Cardiovascular diseases (CVD), a cluster of conditions that affect the heart and blood vessels which 
include stroke, heart failure, and peripheral vascular disease, often share similar risk factors, and are 
presently a leading cause of death in South Africa and sub-Sahara Africa. According to the World 
Health Organization (WHO), CVD are the number one cause of preventable mortality and morbidity 
accounting for about 30% of all deaths world-wide with 80% of the total deaths occurring in 
developing countries. The sudden increase in CVD in low income areas such as those in the SSA is 
fuelled by the changes in lifestyle associated with urbanisation and westernisation. The burden of 
CVD in a population results from the frequency of major cardiovascular risk factors, and while these 
risk factors are diverse, hypertension (HT) remains the commonest risk factor for CVD, particularly 
in economically developing communities. Causes for HT itself are variable and can be of 
behavioural or environmental origin.   
More importantly, habitual Na
+
 intake has continuously been implicated in the development of HT. 
People of African origin have a higher prevalence of HT, and a prospective study has indicated that 
South African adults consume an average of 8.1g of salt (3,240 mg Na
+
 ≈ 140mmol Na+) daily as 
opposed to the WHO’s recommended daily intake of 6g/d of salt (2,400mg Na+ ≈ 104mmol Na+). 
Furthermore, South African blacks report adding salt in most cooking than their white counterparts, 
and that discretionary salt intake is more in blacks than in whites. Therefore, it is possible that Na
+
 
intake may impact on BP more in people of African ancestry compared to white people. However, up 
to now, data are inconsistent regarding this matter therefore more studies still need to be done. 
 
Indeed, the management of HT is crucial, but it requires the accurate assessment of net Na
+
 balance 
in the body to establish well-founded relationships, and previously, the reliability of the method used 
to estimate dietary Na
+
 intake in a population of African ancestry living in SOWETO had not been 
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validated. Therefore the validation of estimates of Na
+
 intake is essential for the proper analysis of 
the relationship between Na
+
 intake and BP in this population. Therefore, in the current study I 
aimed to determine the variation in daily Na
+
 intake over a 7 day period and to see if a single 24-hour 
urine collection provides information on Na
+
 intake which accurately reflects the average of a 
subsequent 6 days of urine collection. Also, to determine the relationship between Na
+
 intake and BP 
and check whether daily Na
+
 intake determined from 24-hours of urine collection is more closely 
associated with ambulatory or office BP. In the first chapter (Introduction), I discuss the general 
mechanisms responsible for the development of HT, the methods used to monitor BP, and the impact 
of dietary Na
+
 on HT based on literature. In chapter two, I explain the methods used to collect data in 
this study. In chapter three I display the results obtained from statistical analysis of the data, and in 
chapter four I discuss the results in contrast to literature and propose possible causes and for the 
findings. This study will add widely to the existing body of knowledge regarding the continuously 
debated relationship between Na+ intake and BP. 
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CHAPTER ONE 
 
INTRODUCTION 
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1 Introduction 
Cardiovascular diseases (CVD), which includes stroke, heart failure, and peripheral vascular disease, 
often share similar risk factors, and are presently a leading cause of death in South Africa and sub-
Sahara Africa (SSA) (MRC Statistics, 2014; Mbewu, 2009). According to the World Health 
Organization (WHO), CVD are the number one cause of preventable mortality and morbidity 
accounting for about 30% of all deaths world-wide with 80% of the total deaths occurring in 
developing countries (Santulli, 2013). Traditionally, infectious diseases and malnutrition have been 
the primary causes of mortality in SSA with little attention to health problems being focused on CVD 
(Gaziano et al. 2006; Alberts et al. 2005). The sudden increase in CVD in low income areas such as 
those in the SSA is compounded by the element of lacking resources to fight CVD in these areas. 
Much of this increase in the prevalence of CVD is fuelled by the changes in lifestyle associated with 
urbanisation and westernisation; a concept initially labelled “the epidemiological transition” (ET) by 
Omran (1971).  
This theory is centred on demographic and socio-economic diversities. Omran's notional perception 
of ET has largely been used in research because it suggests clarifications for changing cause-of-death 
patterns corresponding to different stages of transition (Kandala et al. 2013). The ET embraces four 
stages as they appear in Table 1. In summary, the ET is simply defined by a decline in mortality from 
infections and malnutrition and a rise in non-communicable chronic diseases such as CVD due to a 
shift in determinants and risk factors for these diseases in a population, especially where there is 
constant migration from rural to urban areas (Mbewu, 2009). This rapid migration and transition in 
communities of developing countries in pursuit of economic development propels the dissemination 
of risk factors such as tobacco use, refined foods, and lifestyle divergence allied with high incidence 
of CVD (Lim et al. 2007; Murray et al. 2003). 
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Table 1.1: Epidemiological Transition 
Phase of epidemiologic 
transition 
Details from 
cardiovascular 
disease (%) 
Cardiovascular 
problems 
Risk factors 
Age of pestilence and 
famine 
5 - 10 Rheumatic heart disease, 
infection and deficiency-
induced cardiomyopathy 
Uncontrolled 
infection, 
deficiency 
conditions 
Age of receding 
pandemics 
10 - 35 As above, plus 
hypertensive heart 
disease and 
haemorrhagic stroke 
High-salt diet 
leading to hyper-
tension, increased 
smoking 
Age of 
degenerative 
and man-made 
diseases 
35 - 55 All forms of stroke, 
ischaemic heart disease 
Atherosclerosis 
from fatty diets, 
sedentary  
lifestyle, 
smoking 
Age of delayed 
degenerative diseases 
Below 50 Stroke and ischaemic 
hear t disease at older 
ages 
Education and 
behavioural 
changes leading to 
lower levels of risk 
factors 
 Mbewu, 2009 based on Omran 1971. 
The burden of CVD in a population results from the frequency of major cardiovascular risk factors as 
shown in Figure 1, and while these risk factors are diverse, hypertension (HT) remains the 
commonest risk factor for CVD, particularly in economically developing communities (Salako et al. 
2007; Wiysonge et al. 2004).  
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HT being principally a chronic condition, is characterised by an abnormally raised blood pressure 
(BP) resulting in end organ damage and is firmly circumscribed to arterial blood pressure. It is 
usually asymptomatic and those who develop symptoms generally complain of headaches, visual 
disturbances, nausea, vomiting, and infrequently confusion. Due to its asymptomatic nature, people 
normally develop complications without knowing it; authenticating this condition a “silent killer” 
(Mungati et al. 2014).  
The causes and risk factors for HT itself are interrelated and are based on physiologic states, 
biological markers or other identifiable factors associated with a change in vascular structure and an 
increased blood pressure. These causes depict a multifactorial aetiology and because of this, HT is 
categorised into essential (primary) HT or secondary HT (Kwok et al. 2007). When the cause is 
unknown it is labelled essential HT and usually suggests a genetic link with ancestry. Differently, 
secondary HT is when the cause is identified such as in the case of chronic kidney disease, adrenal 
gland disorders, pregnancy or drug induced HT (Price et al. 2014; Kaplan, 2007). 
Risk factors for HT are characterized as either modifiable or non-modifiable and are often the 
classical risk factors responsible for cardiovascular clinical endpoint and ultimately CVD mortality 
and morbidity (Protulipac et al. 2015).  Non-modifiable risk factors for HT are those practical 
aspects which cannot be attuned and include conventional risk factors such as age, family history 
(genetics), gender, and ethnicity. 
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Figure 1.1: The relations of lifestyle, established and novel risk factors, and cardiovascular disease. 
Assessment and treatment of dyslipidaemia, hypertension, and diabetes are major foci of clinical 
care, practice guidelines, performance measures, and scientific research. These established 
cardiovascular risk factors are strongly influenced by lifestyle, including dietary behaviours, physical 
inactivity, smoking, and adiposity. Adiposity itself is largely a result of poor diet (excess calories) 
and inactivity. Lifestyle risk factors also influence disease risk via effects on other novel risk factors 
such as endothelial function, inflammation/oxidative stress, thrombosis/coagulation, arrhythmia, and 
other pathways. These basic lifestyle habits: poor diet, high Na
+
 intake, physical inactivity, and 
smoking are thus the most proximal risk factors for cardiovascular disease (Mozaffarian et al. 2008) 
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1.1 Risk factors for hypertension 
Non-modifiable risk factors include advancement in age, which is recognised in many studies as a 
major cause of HT (Gamici et al. 2009; James et al. 2006; Brady et al. 2005). It is inescapable and is 
rightfully regarded as an independent risk factor for the development of cardiovascular disorders 
(Gamici et al. 2009). This biological course is accompanied with a decline and alteration in 
physiological functions of many organs involved in regulating BP. Furthermore, an enormous 
amount of proof supports the presence of a considerable genetic component in BP regulation with 
approximately 20% to 60% of the population variability in blood pressure being genetically 
determined (Khullar, 2010; Von-Wowern et al. 2003). Adding to this, recent studies including the 
one conducted by Kouremenos et al (2014) indicated a successful detection and correlation of genes 
that are associated with BP regulation and HT. Coupled with age and genetics, gender is also 
implicated in HT and men are regarded to have higher blood pressure than women through much of 
life irrespective of race and ethnicity (Sandberg and Ji, 2012). Aditionally, with regards to ethnicity, 
there are blatant differences in ethnic and racial groups pertaining to HT and its sequelae such as 
manifestations of CVD. For many years, data from the United States has reliably presented that 
hypertension is more common, more serious, and develops at an earlier age in African Americans as 
compared with White Americans (Agyemang and Bophal, 2002). 
As mentioned previously, excluding non-modifiable risk factors for HT, there are several other 
behavioural and environmental contributory factors to the development of HT and in an effort to 
lessen worldwide prevalence of HT, global strategies and population-based intervention studies 
including Dietary Approaches to Stop Hypertension (DASH) and the Trial of Hypertension 
Prevention (TOHP) II have focused on life style changes such as weight loss and particularly the 
reduction of salt/sodium (Na
+
) intake as a means of lowering BP in a population (He and 
MacGregor, 2010). He et al (2012) indicated that Na
+
 intake is the major cause of raised BP, 
therefore reducing its intake would lessen HT. However, life style changes such as salt reduction 
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should be accompanied by proper understanding of the pathophysiology of HT, and more 
importantly, the methods used to measure BP and categorise HT should be employed with a clear 
consideration for their advantages and disadvantages. 
 
1.2 Blood pressure monitoring 
1.2.1 Conventional blood pressure monitoring  
Due to the multifactorial aetiology of HT, attention should also focus on the methods for assessing 
HT and its successive cardiovascular outcomes. Traditionally, conventional BP (CBP) measurement 
has been the standard monitoring tool in practice for many decades (Conen et al. 2014). The 
European Society of Hypertension (EHS, 2013) has published guidelines for ideal office blood 
pressure measurements techniques. The recommendations of these guidelines are explained in detail 
in Chapter 2 (Methodology). Since accurate diagnosis of HT is crucial in treating those individuals at 
high risk for adverse effects (Williams et al. 2013), it is essential to understood that BP has a natural 
circadian rhythm characterised by a nocturnal dip in pressure and a morning surge in pressure that 
occurs before waking up; a phenomenon not accounted for by conventional BP measurements, thus 
justifying the considerations, interest and reason for the use of a 24-hour BP monitoring (Mancia and 
Verdecchia, 2015; Williams et al. 2013), the ABP monitoring.  
 
1.2.2 Ambulatory blood pressure measurement 
The superior predictive ability of 24-hour ABP monitoring over office measurements is well 
recognized in both cross-sectional and longitudinal studies because it offers a more precise method 
of quantifying BP levels in detecting HT (Grossman, 2013). Although both the CBP and ABP 
monitoring measure peripheral BP in the brachial artery (Rock et al. 2014), the ABP monitoring is 
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deemed superior to CBP because it is able categorise white-coat HT (WCHT), masked HT, daytime 
and night time BP.  
Its major aspect is that it is a reliable tool in predicting target organ damage (Lehmann et al. 2013; 
Hara et al. 2011), and it also provides a better prognostic value for cardiovascular events (Weber et 
al. 2012). The sequence of readings obtained during the patient’s daily activities affords a superior 
assessment of the true BP and provides information on BP variability, circadian rhythms, and the 
effects of environmental and emotional conditions on BP levels (Mancia and Verdecchia, 2015; 
Grossman, 2013). A sizeable fraction of patients have normal ABP readings, but somehow, their BP 
readings are elevated when measured in the office; the “WCHT”, a term commonly used to denote 
patients whose BP is only high in the medical or office setting, but is normal when they are going 
about their daily activity (Dolan et al. 2005). Even though WCHT has a comparatively 
nonthreatening outcome compared to sustained mild hypertension, the adversity of failure to 
recognize it results in inappropriate prescription and lifelong use of antihypertensive medications 
(Dolan et al. 2004).  
On the contrary, patients with masked hypertension have normal office BP but elevated out-of-office 
BP (Ogedegbe and Agyemang, 2010). The prevalence of masked HT varies considerably as observed 
in different studies depending on the population characteristics and the presence and absence of 
antihypertensive treatment.  Other factors which may discriminately increase ABP in relation to 
office BP include increased physical activity, smoking, alcohol use, obesity, and psychological 
factors such anxiety and stress (Franklin et al. 2015; Ogedegbe and Agyemang, 2010). Through its 
ability to detect changes in BP throughout the day, the ABP monitoring can stratify these risk factors 
for HT and improve the physician’s ability to forecast outcomes even in patients who have masked 
HT as recorded by ABP machines during diurnal and nocturnal activities (Siti et al. 2013).  
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 Circadian variations in physiological processes have provoked awareness and interest concerning 
the chronological deviations of BP in healthy humans (Larochelle, 2002); basically, BP fluctuates 
according to the circadian rhythm whereby it decreases during sleep and increases during 
wakefulness (Mahabala et al. 2013). This normal variation in BP is characterised by a 10% to 20% 
reduction in BP from day to night (Karaagac et al. 2014) and subjects who do not exhibit a decrease 
in BP by this percentage are called “non-dippers”, whereas those who display this reduction in BP 
are referred to as “dippers” (Maseko et al. 2006). Some patients show a contradictory rise in BP 
during the night and are referred to as reverse dippers. Daytime BP does not deliver earnest 
prognostic accuracy as compared to night-time BP, this is because night-time BP represents basal BP 
and is a representative of the true BP status of an individual hence in non-dipping BP patterns it can 
be a useful indicator of HT severity if proven to be connected with other influences and 
complications (Mahabala et al. 2013).  
Several studies have revealed that a strong association exist between a non-dipping BP profile and 
increased Na
+
 intake, target organ damage at the cardiac, cerebrovascular and vascular level 
(Karaagac et al. 2012). In a meta-analysis by Fargart et al (1995), it was shown than non-dipping 
pattern in BP accounts for a considerable degree of Left Ventricular Hypertrophy (LVH), Carotid 
Intima Media Thickness (CIMT), and microalbuminuria (Maseko et al. 2006). Numerous factors 
seem to be implicated in the circadian fall in BP during sleep and its subsequent rise upon awakening 
(White, 2007; Kotsis et al. 2005; Seo and Oh, 2002), these changes are mediated by hemodynamic 
parameters, neuro-hormonal factors, and electrolytes such as Na
+
. 
Furthermore, this nocturnal decline in BP relating to the BP circadian rhythm is reported to be 
affected by Na
+
 intake in hypertensives (Koroboki et al. 2012; White, 2007). Therefore, in order to 
manage these patients who are hypertensive, the quantification of the total cardiovascular risk profile 
requires the inclusion of subclinical target organ damage as a quantifiable measure through none 
invasive measurement of the central aortic BP  (Agabiti-Rosei et al. 2007). 
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1.2.3 Central blood pressure  
In addition to the use of ABP monitoring, emerging data from epidemiological studies and clinical 
observations supports that central BP (CNBP) may be more relevant than brachial BP measurements 
in predicting cardiovascular events and target organ damage (Ding et al. 2011). This is because 
CNBP are pathophysiolocally more significant than peripheral (brachial) pressures in the 
pathogenesis of CVD (Agabiti-Rosei et al. 2007). Moreover, CNBP is exerted on the heart, brain and 
kidneys, therefore may be way different than the pressures measured at the arm, particularly in the 
elderly and hypertensive patients and due to exposure of these organs, cardiovascular risk should 
relate better to CNBP (McEniery, 2009).  
Pressures in the large elastic aorta and carotid arteries causes degenerative changes which are fast-
tracked by aging and salt dependant HT. In contrast, peripheral arteries such as the brachial and 
radial arteries are more muscular than elastic, hence they are less influenced by these degenerative 
changes caused by salt dependant HT (Avolio et al. 1983). It is for this reason that aortic CNBP are 
said to be a better surrogate marker for CVD (Rosenwasser et al. 2014). The left ventricle is 
subjected to aortic systolic pressure, the pressure wave generated by this ventricle travels though the 
arterial tree and is reflected at numerous peripheral sites, mostly at resistance vasculature, the small 
muscular arteries and arterioles (Agabiti-Rosei et al. 2007).  
As a result, the pressure waveform recorded at any site in the arterial tree reflect the entirety of the 
forward travelling waveform generated by the left ventricular ejection and the backward waveform 
of the incident wave redirected at peripheral sites (Kuzeytemiz et al. 2013; Agabiti-Rosei et al. 
2007).  If and when the large channel arteries are healthy and compliant, the reflected wave merges 
with the incident in the proximal aorta during diastole and thus augments the diastolic BP and 
helping with coronary perfusion (McEniery, 2009; Agabiti-Rosei et al. 2007).  
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On the contrary, when the arteries are stiff, Pulse Wave Velocity (PWV) escalates, speeding the 
incident and reflected waves, and by so doing, the reflected waves merges with the incident wave in 
systole and augments aortic systolic rather than the diastolic pressure which consequently increases 
the ventricular afterload and compromises normal ventricular relaxation and coronary perfusion 
(Krogager et al. 2014; Rosewasser et al. 2014; Agabiti-Rosei et al. 2007). Unlike in brachial 
pressure, the variation in the manner in which central aortic pressure waves generated during systole 
are reflected back to the aorta at erratic velocities is dependent on arterial stiffness (McEniery, 2009). 
Particularly, in hypertensive patients, the pressure waves are prematurely reflected, and as a result 
their return to the aorta is simultaneous with the generation of the next pressure wave, hence the 
outcome is an increase in the CNBP (Rosewasser et al. 2014).  
 
1.3     Salt intake, arterial stiffness and target organ damage 
Notably, more than a few studies have revealed that HT and its causes such high Na
+
 intake increases 
arterial stiffness in all ages (Kuzeytemiz et al. 2013), and in addition, when coupled with other 
cardiovascular risk factors such as hypercholesterolemia, smoking, and diabetes, the incidence of 
arterial stiffness is fuelled even further, and can have differential consequences on both the brachial 
BP, CNBP and eventually target organ damage (Krogager et al. 2014; McEniery, 2009).  
Arterial stiffness assessed by measuring the PWV has been shown to predict cardiovascular 
outcomes such as target organ damage independently of other known risk factors in the general 
population. The carotid-femoral PWV is denoted the gold standard of evaluation (Chen et al. 2015; 
Hansen et al. 2006). The value of PWV in determining arterial stiffness is evident in cardiovascular 
risk stratification (Hamatener et al. 2013). Arterial stiffening progresses from a number of 
multifarious interactions among steady and ongoing changes involving structural and cellular 
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elements of the vessel wall and these vascular adjustments are subject to hemodynamic and other 
factors such as hormones and salt regulation (Zieman et al. 2005) as seen in Figure 3.  
Because increased arterial stiffness is accompanied with structural changes mainly in the medial 
layer of the arteries, and because it is largely instigated by degeneration of the elastic fibre it affects 
the regulation of BP in these arteries. Large artery stiffening promotes target organ because of its 
effect on pressure and flow pulsitility, therefore stiffening of these arteries is important not only as a 
surrogate marker of cardiovascular risk, but also because of the pathophysiological consequences 
(Jain et al. 2014).  Zieman et al (2005) demonstrated that dietary Na
+
 together with an increase in 
age amplifies stiffness of blood vessels, however low-sodium diets in older adults improves arterial 
compliance. Similarly, Na
+
 stimulates vascular smooth muscle tone and modifies vascular wall 
composition; there is obviously a noticeable increase in the medial layer observed with vascular 
smooth muscle hypertrophy and extensive collagen and elastin production (Bragulat et al. 2001). It is 
also suggested that Na
+
 interacts with specific genes involved in the regulation of BP. By reducing 
the production of NO by the NOS, Na
+
 impairs endothelial function (Kaplan, 2007). Coupled with 
other factors, Na
+
 promotes arterial stiffening and hence it is highly implicated in the pathogenesis of 
HT and target organ damage.  
It is therefore important to understand how levels dietary Na
+
 intake could impact on peripheral BP 
and CNBP, a relationship that could not be established in a community of African Ancestry living in 
the South West Township (SOWETO) of Gauteng, South Africa (Michel et al 2012, 2014, Scott et al 
2011, Millen et al 2013). As revealed that both the CNBP and ABP monitoring offers appropriate 
prognostic values associated with target organ damage and arterial stiffness, some data suggests that 
CNBP can be decreased and that non-dipper nocturnal BP can be changed to a dipper pattern through 
salt restrictions (White, 2007; Uzu et al. 1997) which further supports the involvement of Na
+
 in the 
pathogenesis of HT.  
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Figure 1.2: Summary of multiple causes and locations of arterial stiffness. (Zieman et al. 2005)  
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1.4 Dietary sodium  
1.4.1 Patterns of sodium intake 
Worldwide, the regular salt intake per adult is reported to be around 10 g/d (4000 mg/d Na
+
 ≈ 174 
mmol Na
+
), with higher intakes occurring in Asia (Campbell et al. 2014). Ostensibly, South African 
adults consume an average of 8.1g of salt (3,240 mg Na
+
 ≈ 140mmol Na+) daily as opposed to the 
WHO’s recommended daily intake of 6g/d of salt (2,400mg Na+ ≈ 104mmol Na+) (Bertram et al. 
2012). Essentially, in this population, considerable amounts of Na
+
 intake emanates from non-
discretionary intake with the highest proportion being from bread, and other contributions coming 
from margarine, soup mixes and gravies. Charlton et al (2005) conveyed that more South African 
blacks reported adding salt in most cooking than their white counterparts.   
Furthermore, inconsistency did occur between self-reported dietary Na
+
 intake and urinary excretion 
of Na
+
 in blacks as compared to whites which additionally suggested that discretionary salt intake 
(i.e. salt added to food at the table and in cooking) was more in blacks than in whites. As elaborated 
earlier, it is not unusual that blood pressure values with regard to salt intake are dissimilar in blacks 
and whites more especially because of salt sensitivity and irregularities in the physiological control 
of Na
+
 in the body. 
1.4.2 Physiology of sodium regulation  
Sodium is an essential nutrient necessary to maintain physiological homeostasis by its central role in 
sustaining intravascular, extracellular, and intracellular volume (Alderman, 2002). It is mostly 
concentrated in the extracellular fluid (ECF) averaging 140-145mmol/l, as compared to intracellular 
fluid (ICF) compartments where it averages 10mmol/l (Arcand et al. 2009). In addition to its 
involvement in the transport of molecules across cell membranes, it also helps in maintaining the 
electrochemical gradients via the Na/K ATPase pump (Arcand et al. 2009).  
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Sodium ions accounts for nearly 90% of positively charged ions in the ECF, and because of its 
charge properties, precise regulation of this ion is required for impulse conduction along nerve cells, 
muscle fibre contraction, and maintenance of cell membrane potential. By its control of ECF, Na
+
 
regulates blood plasma, blood volume and consequently BP (Alderman, 2002).  
About 95% of ingested Na
+
 is absorbed in the small and large intestines of the gastrointestinal tract 
irrespective of the amount that is consumed, and usually this intake is beyond physiological need 
(Elliot and Brown, 2007). Most of the ingested Na
+
 is excreted via the kidneys, with varying but 
literally small amounts lost in sweat, faeces, saliva and less often semen and menstruation (Meneton 
et al. 2005). In standard physiological conditions, renal excretion of sodium is regulated so that 
balance is maintained between intake and output so as to stabilize ECF volume and maintain BP 
(Karppanen and Mervaala, 2006).  
The body has a number of systems which control BP, but the regulation of BP achieved through 
controlling Na
+
 in ECF is made possible by the kidneys via the “pressure-natriuresis and diuresis 
mechanism”, a model explained by Guyton et al (1972). This theory states that as arterial pressure 
increases beyond normal, the excess pressure increases filtration and causes the kidneys to excrete 
more water and Na
+
 in the urine than are entering the body. Therefore, the ECF and blood volumes 
decrease. Ultimately, this results in a decreased arterial BP which is caused by a decrease in venous 
return back to the heart. The converse is true when there is a decrease in arterial BP.  In addition to 
the kidneys’ ability to auto regulate Na+ reabsorption and excretion in the tubules, supplementary 
mechanism such neuroendocrine feedback mechanisms including natriuretic peptides, and the Renin-
Angiotensin-Aldosterone-System (RAAS) are employed to complement the intra-renal ECF/Na
+
 
regulatory mechanisms (Meneton et al. 2005).  
The RAAS is the most important and well known hormonal system involved in regulating Na
+ 
through a cascade of events shown in Figure 3. Although the RAAS offers the most influential 
16 
 
control on the renal handling of Na
+
, this Na
+
 -retaining, blood pressure raising system is opposed by 
a system involving the hormone atrial natriuretic peptide (ANP), a hormone that induces excretion of 
large amounts of Na
+
 in the kidneys and causes the lowering of BP (Van Thiel et al. 2015; Song et 
al. 2015). 
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Figure 1.3: The Renin-Angiotensin-Aldosterone-System. ANP (Atrial Natriuretic Peptide), BNP 
(Brain Natriuretic Peptide). + Stimulatory signal. – Inhibitory signal. (Marshall and Bangert, 2008). 
 
 
 
18 
 
1.4.3 The impact of dietary sodium on hypertension 
It is largely documented in many studies that an increased Na
+
 intake is associated with an increase 
in BP, and that reduction in Na
+
 is a well-established public health issue (Rhee et al. 2014). Even 
though high Na
+
 intake is a concern, the general homeostatic principle states that there is an 
important physiologic range for intake of all essential nutrients including Na
+
. Based on this concept, 
an intake below the required range for essential nutrients may result in deficiency conditions. On the 
contrary, if the intake exceeds the physiologic range for prolonged periods, adverse effects may 
develop as in the case of HT due to high Na
+
 intake (Karppanen and Mervaala, 2006). 
 
Indeed, the DASH, controlled clinical trial, provided a clear indication that decreasing Na
+
 intake 
will lower BP in hypertensives (Charlton et al. 2005). Although the relationship between BP and an 
increased Na
+
 intake has long been documented, the mechanism of Na
+
-dependent HT still remains 
controversial (Drenjancevic-Peric et al. 2011). The modest relationship between 24-hour urinary 
electrolyte excretion rates and BP has been reported in large epidemiological studies including the 
Intersalt Study (Intersalt Cooperative Research Group, 1988) and the Scottish Heart Study (Smith et 
al 1988) and the lack of relationship between salt intake and BP in epidemiological studies in Africa 
(Hoosen et al 1985, Charlton et al 2005). 
 
1.4.4 Impact of dietary sodium on salt sensitive population 
For many years, data has reliably presented that salt dependant hypertension is more common, more 
serious, and develops at an earlier age in African Americans as compared with White Americans 
(Agyemang and Bophal, 2002).  
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Similarly in Europe, people of African descent compared to those of other ethnic origin have higher 
mortality rates relating to HT (Jones and Hall, 2006; Agyemang and Bophal, 2002). Also, when 
comparing people of African descent to descendants of other ethnic origin, Africans tend to show 
less “dipping” in blood pressure at night, a status strongly associated with higher rates of vascular 
disease (Jones and Hall, 2006). Regardless of past and recent research debates, it still remains an 
epidemiological puzzle to explain the increased risk of HT experienced by people of African 
ancestry when likened to other ethnic groups. A number research papers counting Sowers et al. 
(1988) have long proposed that BP in African lineage is heightened by the incidence of high “salt 
sensitivity” as compared to their ethnic counterparts, though the mechanism responsible for the 
increased incidence of salt sensitivity in blacks is poorly understood. Although inevitable as 
explained previously that Na
+
 is necessary in the human body, literature shows that habitual intake 
of dietary Na
+
 predisposes individuals to HT (Zhang et al. 2013). This is particularly true in the case 
of salt-sensitive hypertensives dwelling in urbanised areas with a relatively high Na
+
 consumption 
(Rassler, 2010). 
 
1.4.5 Nutrient interaction: The sodium-to-potassium ratio 
It has been recognised for a long time that high Na
+
 intake is associated with an increase in blood 
pressure especially in salt sensitive individuals, however the mechanism by which an increase in Na
+
 
intake leads to the development of salt-dependent HT is poorly understood and still remains a topic 
of constant debate (Drenjancevic-Peric et al. 2011). Nonetheless, studies suggest that the 
mechanisms responsible for the development of HT due to Na
+
 could involve other factors such as 
low K
+
 intake (Adregue & Madias, 2014). Other data suggests that the ratio of Na
+
/K
+
 is more 
crucial in BP regulation (Alderman, 2002), and an imbalance in this ratio; as in the case of high 
levels of Na
+
 and low levels of K
+
 intake could be associated with high BP and a greater risk for 
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CVD (Zhang et al. 2013). Other studies have long suggested that high K
+
 intake reduces BP 
significantly (Houstin, 2011), however it now appears that the ratio of Na
+
/K
+
 could be much more 
important than either sodium or potassium alone.   
 
1.4.6 Reduction of dietary Na+ intake 
Owing to global trends in Na
+
 consumption, advocates of salt reduction have conversed a strong 
consensus that reduction in dietary Na
+
 could save lives, health care resources, and ultimately save 
money (Campbell et al. 2015). A number of randomized controlled trials indicate that non-
pharmacological tactics, predominantly the decrease Na
+
 intake will lower BP in hypertensives and 
thus become a means to reduce CVD mortality and morbidity (Charlton et al. 2005). These 
encouraging studies include the already mentioned DASH randomized controlled trial, TOHP II trial, 
and other meta-analysis such as the DASH-sodium trial, the TONE trial, the PREMIER clinical trial 
to mention a few (Tejada et al. 2006). 
  
As a matter of fact, even most health guidelines and the WHO supports the reduction of Na
+
 intake 
to less than 100 mmol/L. In a meta-analysis by Law et al (1991), it was reported that a decrease in 
salt intake of about 50 mmol/day results in BP fall of an average 5 mmHg in both systolic and 
diastolic values. The DASH-sodium trial is unavoidably the most considerable study because it is the 
largest intervention trial. It randomised 412 individuals to either a normal diet or a DASH diet (high 
in fruits and vegetables and low fat dairy products) and placed in them in three categories of salt 
intake of roughly 9, 6, and 3g/d and continued for 30 days.  
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There was significant decrease in BP due to salt restriction from 140 to 110 mmol/day, adding to 
this, BP reduction was seen with a decrease in salt intake from 100 to 65 mmol/day which was 
associated with a fall in BP of 6.7 mmHg systolic and 3.5 mmHg diastolic BP respectively, but this 
was also influenced by the DASH diet itself (Karpppanen and Mervaala, 2006; O’Shaughnessy, 
2006). Likewise, the TOHP II also showed that Na
+
 reduction of 100 mmol/day with or without 
weight loss was associated with a reduced risk of hypertension by 20% (O’Shaughnessy, 2006; 
Kumanyika et al. 2005).  
Even though there is extensive epidemiological data which convincingly demonstrate a relationship 
between Na
+
 intake and hypertension, there is still some reproach to this relationship. Statistical 
significance of these surveys have principally depended on maverick populations where the 
consumption of Na
+
 was either too high or too little. Also, no BP-Na
+
 relationship was detected in 
the majority of populations whose consumption was between the extreme lower and upper limits 
(Weinberger, 1999).  
These disparities are what drives the constant debate known as “The Salt Saga” which is propelled 
by different views on the role of Na
+
 in the pathogenesis of HT (Logan, 2002). Some scholars are 
convicted to the idea that the average BP value in a population is largely determined by the average 
Na
+
 consumption (Logan, 2002; Weinberger, 1999), and other contradictory perceptions suggest that 
there is an individual variation with regard to dietary Na
+
 vulnerability where some individuals 
become hypertensive while others remain normotensive with the same levels of salt intake further 
advising that others are “salt sensitive” while others are “salt resistant” (He et al. 2010; Meneton et 
al. 2005). Despite long-standing reports advocating for a reduction in dietary Na
+
 intake, recent 
studies have raised queries regarding potential adverse effects associated with low Na
+
 intake 
importantly on cardiovascular outcomes and related mortality (Oparil, 2014).  
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However O’Donnell et al (2014) revealed that low Na+ was associated with increased risk for CVD 
and therefore a targeted approach to Na
+
 restriction would be more rational than a population wide 
approach which assumes that everyone consumes too much Na
+
. Appropriate methodology is 
required to collect high-quality evidence in order to determine the risk and benefits of low Na
+
 
intake, hence the methods for estimating Na
+
 intake are important. 
 
1.4.7 Estimating daily Na+ intake  
For obvious health reasons, the evaluation and management of HT is crucial, and it requires the 
accurate assessment of net Na
+
 balance in the body (Rhee et al. 2014). There are several methods for 
evaluating Na
+
 intake such as dietary recall, a food frequency questionnaire (FFQ), spot urine 
collection, and 24-hour urine collection for the determination of 24-hour Na
+
 excretion. The 
measurement of a 24-hour urinary Na
+ excretion is considered the “gold standard” method for 
estimating Na
+
 intake in a population (Zhang et al. 2014; Ortega et al. 2010).  
Other methods such as the use of dietary recall and FFQ have numerous flaws and are often 
accompanied with under reporting of Na
+
 intake from participants, for example; accurate reporting of 
dietary recall requires a high degree of motivation and literacy from the participants and enthusiasm 
from the researcher (Charlton et al. 2005; McLean, 2014). Low income countries do not have 
resources for nutritional monitoring of intake (Bentley, 2006). Intake can be underrated due to 
difficulty in quantifying discretionary Na
+
 intake (McLean, 2014). Casual spot urine specimens may 
be useful as alternative methods (Brown et al. 2013); however, Ji et al (2012) indicated that the 
validity and reliability of this method is uncertain. Furthermore he stated that extensive research, 
comprising the use of appropriate study design and statistical testing is essential to conclude on the 
effectiveness of this method.  
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Based on frequently encountered errors attributable to other methods of assessment, the use of a 24-
hour urine collection for estimating Na
+
 intake in individuals and in a population remains a preferred 
method of measurement. It appropriately characterises each patients’ mean urinary Na+ output as an 
index of intake; it is also used to confirm the efficacy of other assessment methods of Na
+
 intake 
(McLean, 2014; Rhee et al. 2014). Expectedly, this method assumes that in a state of Na
+
 balance, 
urinary Na
+
 excretion equals Na
+
 intake.  
 
This technique of measurements has therefore been used to assess relationships of Na
+
 intake with 
BP levels. However, this approach assumes that the human diet varies little in Na
+
 content from day 
to day. In reality, daily variations in Na
+
 intake may occur depending on desire and food availability 
(Luft et al. 1982). Indeed, the variable relations noted to occur between urinary electrolyte excretions 
rates and BP in previous large epidemiological studies including the Intersalt Study (Intersalt 
Cooperative Research Group, 1988) and the Scottish Heart Study (Smith et al 1988) and the lack of 
relationship between salt intake and BP in epidemiological studies in Africa (Hoosen et al 1985) may 
also reflect the assumption that the human diet varies little in Na
+
 content from day to day. To avoid 
this assumption, a 7-day urine collection accounts for daily variations in the intake of Na
+
. 
Nevertheless, few studies are available where the intake of Na
+
 has been determined from 7-day 
consecutive urine collections (Liu et al. 1979). Importantly, whether the weak relations between Na
+
 
intake, determined from 24-hour urine Na
+
 excretion, and BP are accounted for by the assumption 
that the human diet varies little in Na
+
 content from day to day, has not been determined because 
there is no data available for a 24-hour urine collection carried out for 7-days consecutive (Liu et al. 
1979). Henceforth, in an attempt to decrease the prevalence of HT, accurate BP measurements 
supplemented by accurate dietary data such as a 24-hour urine collection carried out for prolonged 
periods (i.e. 7-consecutive days) is essential. 
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1.4.8 Objectives 
The objectives of the present study were therefore to determine: 
1)  the variation in daily Na
+
 intake over a 7-day period and to see whether a single 24-hour 
urine collection provides information on Na
+
 intake which accurately reflects the average of a 
subsequent 6 days of urine collection. 
2) the relationship between Na
+
 intake and blood pressure and check whether daily Na
+
 intake 
determined from 24-hours urine collection is more closely associated with ambulatory, central or 
office BP. 
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2.1 Study   participants 
The study was approved by the University of the Witwatersrand Committee for Research in Human 
Subjects (approval number: M15-05-24) and forms part of the ongoing African Project on Genes in 
Hypertension and the study design  has  been  described  in  brief  in  publications  (Shiburi et al, 
2006; Maseko et al. 2006). South Africans of black African ancestry from nuclear families of the 
predominant chiefdoms (tribes) of Nguni, Sotho and Venda with common ancestral backgrounds 
were randomly recruited from a metropolitan area of Johannesburg (SOWETO). Nuclear families 
were recruited if at least one or two offspring of at least 17 years of age and one or both parents were 
available for examination. There was no upper age limit for the participants; a lower age limit was 
included as BP rapidly increases with age below this value. Six hundred and twenty-nine (629) South 
Africans of black African ancestry randomly recruited for the measurement of conventional, 
ambulatory, and central blood pressures and all other anthropometric measurements. Of the 629 
South Africans of black African ancestry randomly recruited for the measurement of BP, all of them 
had complete conventional BP measurements, 489 had complete ABP measurements, and 597 had 
complete urine collection. 
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Figure 2.1. Examples of ceremonial residences where people were recruited for this study. 
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2.2 Clinical, demographic and anthropometric measurements 
Subjects completed a standard questionnaire. In order to avoid translational errors, the questionnaire 
was not translated into an African language, but study assistants familiar with all languages spoken 
in these townships and who either previously lived in SOWETO or currently reside in SOWETO 
assisted with the completion of each questionnaire. Only same sex assistants were used to assist each 
family member with the completion of the questionnaire. Assistance was only provided when 
requested. The majority of subjects were reasonably proficient in English. Study assistants first 
visited homes of subjects that agreed to participate in the study in order to develop a trusting 
relationship. The questionnaire was only completed at a subsequent clinic visit and then ambiguities 
checked by performing a follow-up home visit. If family members were absent at follow-up home 
visits, data was checked with them personally via telephonic conversations whenever possible.   
Ambiguities in answers to the questionnaire were detected by an independent observer prior to the 
second home visit.  The questionnaire requested specific answers to date of birth, gender, previous 
medical  history,  the presence of hypertension, diabetes mellitus and kidney disease, prior and 
current drug therapy (analgesic use included), prior and current occupation, level of education, 
smoking status (including the number of cigarettes smoked in the past and at the present time), daily 
alcohol consumption (beer, traditional beer or other forms of alcohol and the daily quantity), caffeine 
consumption (number of cups of tea or coffee and whether they are decaffeinated and the number of 
fizzy or cola drinks a day), exercise frequency and family history of hypertension and cardiovascular 
events. For females, menstrual history, history of pregnancies and oral contraceptive use was 
evaluated. Most of the questions simply required a “Yes”-“No” answer, but understanding was 
assessed by requesting some short answers.  
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If subjects were unable to provide the name of medication taken these were obtained on the second 
home visit. Although a crude assessment of SE status (SES) was calculated from the combined levels 
of education, present occupations and annual income, these data have not been analyzed at this point 
as an appropriate score has not been derived. 
 
2.3 Conventional blood pressure measurements 
Trained nurse/technician observers measured BP using a standard mercury sphygmomanometer 
during two home visits and a clinic visit. These were not doctors as they are perceived by the 
community as being in positions of authority and hence may elicit “white-coat” effects. After being 
trained in the procedure, including being shown the pitfalls of BP measurement (positioning of the 
cuff, positioning of the arm, first estimating systolic BP using a radial pulse measure in order to 
avoid increasing cuff pressures too high, detecting auscultatory gaps, releasing valve pressure at the 
correct speed,  using  the  correct  cuff  size,  etc.), assistants had to demonstrate an ability to perform 
the procedure on 20 subjects. The study assistants were then tested on their ability to measure BP in 
two ways. First they were asked to measure BP on a separate group of 20 subjects including patients 
with hypertension and their readings had to be within 4 mm Hg of an experienced investigator’s 
readings obtained with a stethoscope with two ear pieces. Second, study assistants were asked to 
watch a video showing a simulated mercury column with Korotkoff sounds where observers were 
tested on their ability to detect phase I and V sounds under different circumstances including in the 
presence of a wide auscultatory gap and where phase V Korotkoff was taken as a “muffling” rather 
than a “disappearance” of sounds (Blood Pressure Measurement, British Medical Journal, BMA 
House London). To qualify as observers all readings (n= 20) had to be within 4 mm Hg of the 
reference standard. Assistants who failed on the assessment the first time were given more time to 
practice on subjects and then asked to repeat the tests.  
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Home visits were conducted 3-to-4 weeks apart and the clinic visit occurred between the two home 
visits. A standard cuff with a 12-24 cm inflatable bladder was used, but if upper arm circumference 
exceeded 31 cm, larger cuffs with a 15-35 cm inflatable bladder were used. After 10 minutes of rest 
in the seating position, five consecutive BP readings were taken 30 to 60 seconds apart with the 
subject in a sitting position, followed by a pulse rate count. The cuff was deflated at approximately 2 
mm Hg per second and phase I (systolic) and phase V (diastolic) BP recorded to the nearest 2 mm 
Hg according to the recommendations of the European Society of Hypertension (EHS, 2013). The 
mean of the five measurements taken at the first home visit was recorded as the home BP. Between 
the two home visits subjects were invited the School of Physiology Hypertension Clinic where a 
nurse, following the same procedure as the first home visit, measured the subject’s blood pressure 
under comfortable surroundings. The average of the five readings was taken as the office BP. In  the  
present  study  quality  control  of  conventional  BP  assessments  was assessed as previously  
described  (Kuznetsova  et al. 2002). A diagnosis of hypertension was made if subjects were 
receiving antihypertensive therapy and/or if the average of the mean values for the home and clinic 
readings was 140/90 mm Hg. 
 
2.4 Anthropometric measurements 
Body height, weight, waist and hip circumference and triceps and subscapular skin-fold thickness 
(Harpenden Skinfold Calliper, Bedfordshire, UK) were measured during the clinic visit by a trained 
observer. Height and weight were measured with the participants standing and wearing indoor 
clothes with no shoes. Waist circumference and hip circumference were measured according to 
conventional techniques (World Health Organization, 2003). Body mass index was calculated as 
weight in kilograms divided by the square of height in meters and waist-to-hip ratio calculated as an 
index of central obesity. 
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Figure 2.2.  Hypertension clinic in the School of Physiology.  Bottom picture shows reception area 
and the top picture is the general clinical room. 
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2.5 Blood sampling 
Blood samples were obtained on the day of the clinic visit and sent to the NHLS to perform a full 
blood count and differential count, to measure urea, creatinine and electrolyte concentrations, to 
assess liver function (from alanine transaminase, aspartate transaminase, gamma gluteryl   
transaminase,   alkaline   phosphatase,   albumin,   total protein and plasma albumin,  total bilirubin, 
and conjugated and unconjugated bilirubin concentrations) and  plasma  urate  concentrations, to  
obtain  a  lipid  profile  (total cholesterol, low density lipoprotein cholesterol concentrations, high 
density lipoprotein cholesterol  concentrations  and  triglyceride  concentrations),  a  blood  glucose 
measurement,  percentage  glycated  haemoglobind  (HbA1c)  and  a  follicle  stimulating hormone 
concentration in females. These data were used to identify medical conditions, syndromes that may 
affect BP and to confirm menopausal status in females.  
A “spot” urine  analysis  was  also  performed  to  screen  for  major  clinical  conditions,  such  as 
diabetes mellitus and renal pathology. The NHLS was utilized for blood measurements to ensure 
reproducibility and reliability as these laboratories have been accredited as fulfilling all criteria of 
“good laboratory practice” (GLP). In those subjects without a prior history of diabetes mellitus, an 
HbA1c rather than a fasting blood glucose concentration was utilized in the APOGH study to assess 
blood glucose control. 
 
2.6 Urinary sodium and potassium excretion 
Timed  urine  samples  were  obtained  over  at  least  a  24-hour  period  after discarding urine 
obtained immediately prior to the collection period. Urine Na
+
, K
+
, and creatinine concentrations 
were measured by the National Health Laboratories (NHLS) accredited for these measurements.  
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Twenty-four hour urine Na
+
 and K
+
 excretion rates were calculated from the product of urine volume 
and urine electrolyte concentration. Creatinine clearance was determined from the product of urine 
volume and urine creatinine concentrations/plasma creatinine concentration. The quality of urine 
samples was determined by constructing regression relations between 24-hour urine creatinine and 
body weight and 24-hour urine volume and age in gender-specific groups. Based upon the 95% 
confidence intervals for each group, a 24-hour urine sample was considered acceptable if 24-hour 
urine creatinine (mmol) was >3.5 and <35 for males and >3.5 and <30 for females. Samples with 
urine volumes <300 mls/day were also assumed to be incomplete urine collections. These approaches 
are standard approaches and have been published on numerous occasions by other groups 
(Kuznetsova et al. 2004).  
 
2.7 Validation of estimates of urinary sodium and potassium excretion 
Urine samples were collected from the participants over a 24-hour period for seven consecutive days 
for each participant to validate if the method of estimating Na
+
. Each participant was issued a urine 
collection bottle and was advised to discard the urine sample into the bottle in the morning and 
record the time. The urine bottles were then collected from each participant the following morning. 
A new bottle was issued to the participant on each consecutive day and this was continued for 7-days 
in order to determine the average excretion of Na
+
 and K
+
 in the urine over a 24-hour period. Urine 
was analysed by the NHLS as explained above. 
 
2.8 Ambulatory blood pressure measurements 
On the same day as 24-hour urine samples were obtained, 24-hour ambulatory BP monitoring was 
performed using oscillometric monitors (SpaceLabs, model 90207) (see Figure 6).  
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Ambulatory monitors were calibrated monthly against a mercury manometer. The non-dominant arm 
was selected for BP monitoring. The size of the cuff was the same as that which was used for 
conventional BP measurements. The monitors were programmed to measure BP at 15-minute 
intervals from 06:00 to 22:00 and then 30-minute intervals from 22:00 to 06:00. Subjects kept a diary 
card for the duration of the recordings to note the time of going to bed in the evening and getting up 
in the morning. The times when going to bed and getting out of bed in the morning were used to 
determine the awake and sleep periods of the day. Subjects were also asked to record the time when 
taking medication in those receiving medication and any times when they either smoked or took 
caffeine-containing or alcoholic beverages. Subjects were asked to pursue their normal daily 
activities and to keep the cuff arm steady during measurements. From the subject’s diary card data 
we determined the awake and asleep periods. On average the subjects went to bed at 19:00 h and 
woke up at 05:00 h.  
Considering these patterns of daily activities the daytime and night-time intervals were defined as 
time intervals ranging from 09:00 h to 19:00 h and from 23:00 h to 05:00 h respectively. These fixed 
clock-time intervals (Thijs et al. 1992) were defined in order to eliminate the transition periods 
(evening and morning) during which BP changes rapidly in most subjects. On completion of the 
recording, the data were transferred to a computer for analysis. Intra-individual means of the 
ambulatory measurements were weighted by the time-interval between successive recordings (Thijs 
et al. 1992). Participants enrolled in the study whose ambulatory BP measurements did not meet the 
pre-specified quality criteria (more than 20 hours of recordings and more than 10 and 5 readings for 
the computation of daytime and night-time means respectively) were discarded from the analysis. 
Ambulatory BP data were expressed as 24-hour average systolic and diastolic BP, the percentage 
decrease in BP at night (mean day-mean night/ mean day x 100), the difference between day and 
night BP and the ratio of day-to-night BP. 
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Figure 2.3.   Spacelabs   model   90207   ambulatory   BP   monitor   (upper   panel)   and 
representative data obtained for analysis purposes (lower panel). 
 
 
36 
 
2.9 Pulse wave analysis 
Central BP, Pulse Pressure (PP), aortic PWV and AIc were estimated using techniques previously 
described (Shiburi et al.  2006). To determine central pressures and the pressure components, after 
participants had rested for 15 minutes in the supine position, arterial waveforms at the radial 
(dominant arm) pulse were recorded by applanation tonometry during an 8-second period using a 
high-fidelity SPC-301 micromanometer (Millar Instrument, Inc., Houston, Texas) interfaced with a 
computer employing SphygmoCor, version 6.21 software (AtCor Medical Pty. Ltd., West Ryde, 
New South Wales, Australia). Recordings where the systolic or diastolic variability of consecutive 
waveforms exceeded 5% or the amplitude of the pulse wave signal was less than 80 mV were 
discarded.  
The pulse wave was calibrated by manual measurement (auscultation) of BP taken immediately 
before the recordings. From a validated inbuilt transfer function an aortic waveform was generated 
from which central systolic, diastolic and mean arterial BP were derived. The magnitude of the 
forward pressure component (P1) was determined as the difference between the inflection point at 
the end of the first systolic shoulder and central diastolic BP (i.e. the height of the first systolic 
shoulder).  
The magnitude of the augmented pressure wave (AP) was determined as the difference between 
central systolic BP and the inflection point at the end of the first systolic shoulder. Central PP (PPc) 
was calculated as the difference between central systolic BP and central diastolic BP and mean 
arterial pressure (MAP) was calculated as [central diastolic BP + 1/3(central PP)]. Although 
applanation tonometry at the carotid artery is the most accurate non-invasive assessment of the 
forward and augmented pressures, carotid tonometry cannot be reliably applied in obesity (Laurent et 
al. 2007).  
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Considering the likelihood of obesity in the study participants, I therefore assessed the pressure 
components of PPc using radial tonometry. Central AIc was determined as the augmented pressure 
wave/PP, expressed as a percentage. The reflected wave transit time (RWTT) was determined from 
the beginning of the incident wave to the end of the first systolic shoulder (i.e., duration of the first 
systolic shoulder) (Mitchell et al. 2004) Aortic PWV was measured from sequential waveform 
measurements at carotid and femoral sites as previously described (Shiburi et al. 2006).  
The distance which the pulse wave travels was determined as the difference between the distance 
from the femoral sampling site to the suprasternal notch, and the distance from the carotid sampling 
site to the suprasternal notch. Pulse wave transit time i.e. the time it takes the pulse wave to travel 
from the carotid to the femoral site, was determined as the difference between the times taken to 
generate the femoral and carotid pulse waveforms. To assess the differences in time of the generation 
of the femoral and carotid pulse waveforms, a single lead electrocardiogram was performed 
concurrently with pulse waveform sampling. Aortic PWV was calculated as distance (meters) 
divided by transit time (seconds).  
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Figure 2.4: Example of a pulse wave recording obtained to determine central haemodynamics. The 
figure shows the radial artery pulse wave obtained from applanation tonometry (lower left panel) and 
the aortic pulse wave derived from a population-based transfer function built into the software (lower 
right panel). The first and second systolic shoulders are identified. See text for a further description. 
Quality control assessments are shown in the top panel. Sp, systolic blood pressure (BP); Dp, 
diastolic BP; MP, mean arterial pressure; PP, pulse pressure. 
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Figure 2.5: SphygmoCor device coupled to an applanation tonometer used to determine central 
(aortic) haemodynamics and aortic PWV. 
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Figure 2.6: Examples of femoral and carotid artery pulse waves obtained using applanation 
tonometry from the same participants. Together with simultaneous electrocardiographic (ECG) 
recordings aortic PWV (PWV) is calculated. The arrows indicate the time between electrical events 
and the arterial pressure changes in the carotid and femoral arteries used to calculate PWV. See text 
for a further description. 
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2.10 Definitions and analysis 
Definitions for hypertension from auscultatory measurements (≥140 mmHg systolic BP or 90 mmHg 
diastolic BP) and ambulatory BP (≥130 mmHg systolic BP or 80 mmHg diastolic BP) values were 
based on published guidelines (World Health Organization; Guidelines Committee of the European 
Society of Hypertension, 2013; O’Brien et al. 2003). The presence of hypertension was identified if 
subjects were either receiving antihypertensive medication, or had an elevated auscultatory BP value 
obtained in a clinic environment. Overweight and obesity were defined using body mass index 
thresholds of between 25-29.9 kg/m
2
 for overweight and ≥30 kg/m2 for obesity. 
Database management and statistical analyses were performed with SAS software, version 9.4 (The 
SAS Institute Inc., Cary, North Carolina, USA). Data from individual subjects were averaged and 
expressed as mean SD. The Χ2-statistic was used to compare proportions. Comparisons between 
normotensives, hypertensives aware of their condition and hypertensives unaware of their condition 
and not receiving treatment for it were made using an ANOVA when no adjustments for 
confounding variables were required and multivariate regression analysis when adjustments were 
required.  
To determine whether awareness and treatment of hypertension was an independent  determinant  of  
electrolyte  intake,  covariates  included  in  the  regression model were age, gender, BMI, tobacco 
and alcohol intake, the class of antihypertensive agent  employed  and  the  presence  or  absence  of  
diabetes  mellitus. To identify the predictors of 24-hour ambulatory BP, stepwise multivariate 
adjusted regression analysis was performed with age, gender, antihypertensive medication, the 
presence or absence of diabetes mellitus or abnormal blood glucose control, indices of adiposity, 24-
hour electrolyte excretion rates and urine Na
+
:K
+
 ratio included in the regression model.  
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Probability values were obtained with further adjustments for non-independence of family members 
(mixed model as outlined in the SAS package).To identify the predictors of indices of nocturnal 
decreases in BP, stepwise regression analysis was performed with age, gender, the presence or 
absence of hypertension, antihypertensive medication, the presence or absence of diabetes mellitus or 
abnormal blood glucose control, indices of adiposity, 24-hour electrolyte excretion rates and urine 
Na
+
:K
+
  ratio used in the regression model. Again, probability values were obtained with further 
adjustments for non-independence of family members (mixed model as outlined in the SAS 
package). Importantly, adjustments for age, gender, the presence or absence of hypertension, the 
presence or absence of antihypertensive medication, the presence or absence of diabetes mellitus or 
abnormal blood glucose control, and adjustments for non-independence of family members were 
made in all regression analyses, whereas. BMI, waist circumference, waist-to-hip ratio and skin-fold 
thickness were assessed in separate models from each other, and electrolyte excretion rates were 
assessed in models separate from those with urine Na
+
:K
+
 ratios. 
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CHAPTER THREE 
 
RESULTS 
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Table 3.1 gives a description of the demographic, anthropometric, and general clinical characteristics 
of the participants in the present study. These characteristics include age, BMI, blood pressure, 
urinary Na
+
 and K
+
 excretion rates, alcohol consumption, smoking and diabetes status. The   mean 
age of participants was 43.9±18.4 with 64% of participants being women. The mean BMI of the 
group was 29.2±7.9, and 67% of participants were either overweight (24%) or obese (43%). Thirty-
seven percent (37.1%) of the sample population was hypertensive, 23.0% consumed alcohol 
regularly, 16.9% smoked, and 12.2% had diabetes mellitus or an HbA1C >6.1%. Table 3.2 gives the 
haemodynamic characteristics which include the clinic and home blood pressure value of the 
participants. The mean and standard deviation is recorded for all home and office blood pressure 
parameters. Both systolic and diastolic blood pressure measurements for the average of the 24-hour 
ABP, daytime ABP, night time ABP, central blood pressure, pulse pressure and conventional blood 
pressures are shown in Table 3.2. Moreover, Daytime systolic and conventional systolic BP are 
higher than normal BP values.   
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Table 3.1:  Characteristics of the study population 
BMI, body mass index; ± values are the standard deviation; whr, waist-to-hip ratio 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Number 629 
Age (years) 43.9 ± 18.4 
Female % 64 
BMI Females 31.5 ± 8.2 
BMI Males 24.9 ± 5.3 
Whr 0.84 ± 0.09 
% Hypertensive 37.1 
% Diabetic  12.2 
Regular alcohol (% subjects) 23.0 
Regular tobacco (% subjects) 16.9 
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Table 3.2:  Heamodynamic characteristics  
Index Mean SD P5 P50 P95 
24 hour SBP 118.2 14.4 99.9 115.0 146.7 
24 hour DBP 72.2 9.4 58.8 71.3 90.5 
Daytime SBP 122.8 14.2 103.9 119.9 152.2 
Daytime DBP 77.4 9.6 64.3 76.0 96.2 
Night-time SBP 110.9 16.7 90.1 106.8 145.5 
Night-time DBP 64.4 11.0 49.6 62.7 84.4 
SBPC 131.1 22.7 102.4 127.6 175.2 
DBPC 84.7 12.4 68.4 83.2 106.4 
C_SP 122.5 23.5    
C_DP 85.5 12.8 68.0 84.0 109.0 
C_PP 37.0 16.2 18.7 34.1 66.9 
P_PP 46.3 17.4 26.0 44.0 78.0 
PPC 46.3 15.8 27.2 42.8 78.4 
SBP, systolic blood pressure; DBP, diastolic blood pressure; SBPC, conventional systolic pressure; 
DBPC, conventional systolic blood pressure; C_SP, central systolic pressure; C_DP, central diastolic 
pressure; C_PP, central pulse pressure; P_PP, peripheral pulse pressure; PPC, conventional pulse 
pressure. 
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Table 3.3 gives the electrolyte excretion rates, urine electrolyte concentration, blood electrolyte 
concentration, and the creatinine clearance values of the participants. The average 24-hour urinary 
Na
+
 excretion rate was 111.2 mmol/day, well above the RDA for Na
+
 intake of 100 mmol/day.The 
24-hour urinary K
+
 excretion rates were 28.9 mmol/day way lesser than the RDA intake for K
+
 of 
120 mmo/day. No major differences were noted in urine volumes between the participants. On 
multivariate analysis, a younger age was the only independent determinant of 24-hour urinary Na
+
 
excretion. Data also shows serum values of creatinine, magnesium, glucose and glycated 
hemoglobin.   
Table 3.4 shows how renin levels influence changes in blood pressure. Renin was divided into 
tertials and correlated with blood pressure. The relationship between renin and each blood parameter 
i.e. systolic and diastolic of 24-hour ABP, daytime ABP, night time ABP, conventional BP was 
studied as shown in Table 3.4. Table 3.5 shows analysis of correlation between blood pressure and 
urinary Na
+
 excretion rate. Although daytime ABP appears to be greater than nighttime ABP in the 
participants due to a decline in BP that occurs at night, none of the blood pressure parameters 
(systolic and diastolic) i.e. 24-hour ABP, Daytime ABP, night time ABP, conventional BP and 
central blood pressure was associated with Na
+
 intake independent of age. Aldosterone, renin, and 
renin ratio versus blood pressure was correlated and appears in Table 3.6. The ratio of aldosterone to 
renin (ARR) was significantly associated with different blood pressure parameters independent of 
age.   
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Table 3.3: Electrolytes values 
Index  Mean SD P5 P50 P95 
Bsug 5.4 2.7 3.6 4.7 9.0 
SCRT 77.5 34.1 50 7 105 
SMG 0.8 0.1 0.7 0.8 0.9 
Crtc (CRT) 7.9 5.8 1.0 7.3 17.9 
Crt 10.8 11.2 1.2 7.6 31.2 
K
+
  28.9 21.8 5.0 24.3 69.2 
Na
+
  111.2 83.2 22.0 94.3 237.6 
Nac 88.8 58.3 19 77 204 
Nak  4.4 2.4 1.8 3.9 9.2 
crcl 2.3 3.2 0.2 1.4 7.6 
Ghb 6.1 1.4 5.3 5.8 8.4 
Bsug (mmol/l), blood glucose; scrt (µmol/l), serum creatinine; smg (mmol/l), serum magnesium; 
Crct (mmol/l), urine creatinine concentration; K
+
 (mmol/l), potassium; Na
+
 (mmol/l), sodium; Nac, 
urine sodium concentration; Nak, sodium-potassium ratio; crcl, creatinine clearance; Ghb (g/dl), 
glycated haemoglobin.  
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Table 3.4 Tertials of renin  
 
RENIN LEVELS 
 < 5.7 5.7 - 13.5 13.5 - 33 
BLOOD PRESSURE    
SBP24 123 ± 16.8 116.9 ± 13.5 114.7 ± 13.4 
DBP24 75.9  ± 11.4 72.2 ± 9.0 70.2 ± 9.5 
SBPN 116.5 ± 19.5 109.7 ± 15.3 107.6 ± 10.8 
DBPN 68.4 ± 12.8 64.4 ± 10.9 62.4 ± 10.8 
SBPD 126.7 ±16.4 121.3 ± 13.3 119.3 ± 13.4 
DBPD 80.6 ± 11.6 77.2 ± 8.9 75.4 ± 9.8 
SBPC 136.4 ± 23.3 127.3 ± 22.1 124.2 ± 19.3 
DBPC 87.7 ± 12.6 83.1 ± 12.6 81.6 ± 11.1 
SBP24, 24-hour systolic blood pressure; DBP24, 24-hour diastolic blood pressure; SBPN, night-time 
systolic blood pressure; DBPN, night-time diastolic blood pressure; SBPD, daytime systolic blood 
pressure; DBPD, daytime diastolic blood pressure; SBPC, conventional systolic pressure; DBPC, 
conventional systolic blood pressure. 
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Table 3.5: Relationship between blood pressure and urinary sodium and potassium 
Blood Pressure Urinary Na
+
 Urinary K
+ 
Urinary Na
+
/K
+
 
SBP24 0.1715 0.2991 0.0004 
DBP24 0.5950 0.2807 0.1259 
SBPN 0.6984 0.3640 0.0011 
DBPN 0.2516 0.3563 0.2658 
SBPD 0.1581 0.2806 0.0011 
DBPD 0.6828 0.3006 0.2490 
SBPC 0.4161                                                           0.2405                0.0040 
DBPC 0.5890 0.3872 0.1732 
SBP24, 24-hour systolic blood pressure; DBP24, 24-hour diastolic blood pressure; SBPN, night-time 
systolic blood pressure; DBPN, night-time diastolic blood pressure; SBPD, daytime systolic blood 
pressure; DBPD, daytime diastolic blood pressure; SBPC, conventional systolic pressure; DBPC, 
conventional systolic blood pressure 
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Table 3.6: Aldosterone, renin, and renin ratio versus blood pressure 
 
                 RENIN ALDOSTERONE ARR 
   
r p r p r p 
      
SBP24 0.08 0.0294 0.10 0.2804 0.26 <0.0001 
DBP24 0.10 0.0122 0.07 0.4440 0.27 <0.0001 
SBPN 0.07 0.0393 0.09 0.6938 0.26 <0.0001 
DBPN 0.09 0.0145 0.06 0.9262 0.26 <0.0001 
SBPD 0.08 0.0317 0.09 0.3502 0.23 <0.0001 
DBPD 0.08 0.0164 0.07 0.3818 0.23 <0.0001 
SBPC 0.10 0.0131 0.08 0.3163 0.26 <0.0001 
DBPC 0.10 0.0002 0.10 0.7460 0.23 <0.0001 
       
ARR, Aldosterone renin ratio; SBP24, 24-hour systolic blood pressure; DBP24, 24-hour diastolic blood 
pressure; SBPN, night-time systolic blood pressure; DBPN, night-time diastolic blood pressure; SBPD, 
daytime systolic blood pressure; DBPD, daytime diastolic blood pressure; SBPC, conventional systolic 
pressure; DBPC, conventional systolic blood pressure. 
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Figure 3.1 shows the daily variations in Na
+
 excretion as an index of intake. The figure shows that 
there is little change from one day to the next throughout the seven consecutive days with regards to 
Na
+
 intake. It also clearly shows that the 24-hour urinary Na
+
 excretion measurements can be 
collected at any day of the week and is not dependant on certain days of the week. Figure 3.2 
illustrates that the first day of urinary Na
+
 collection is similar to the average of the subsequent six 
days collection and that the first day collection is as good as the average of the subsequent six days. 
Figure 3.4 and figure 3.5 depict similar findings to figure 3.1 and figure 3.2 respectively with the 
exception that the results displayed in figure 3.4 and figure 3.5 are for 24-hour urinary excretion of 
K
+
. The figures show that there is little variation in the intake of K
+
 in the population.  Figure 3.3 is 
the Bland-Altman analysis that compares the difference in daily variation and the average change, 
the data shows that there is little difference between the daily averages which shows that daily 
variation in Na
+
 intake is minimal.   
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Figure 3.1: Daily Variations in Na
+
 Intake 
Average values of Sodium intake on different days of the week. Na
+
, Sodium 
 
 
 
 
 
Figure 3.2: One day versus six day average Na
+
 intake   
Mean values of Na
+
 intake based on one day versus the average of six days intake. 
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Figure 3.3: Difference versus average: Bland Altman data 
Average levels of Na
+
 intake versus daily variations in Na
+
 intake.  
 
 
 
Figure 3.4: One day versus six day average K
+
 intake 
Mean values of K
+
 intake based on one day versus the average of six days intake. 
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Figure 3.5: Daily variations in K
+
 intake 
Average values of Potassium intake on different days of the week. K
+
, Potassium 
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Figure 3.6: Relationship between Age and plasma sodium and urinary Sodium excretion 
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Figure 3.6 shows the relationship between Age and concentrations of Na
+
 i.e. plasma Na
+
 and 
urinary Na
+
 excretion. Data obtained from the subjects show that plasma Na
+
 remains fairly constant 
even with an increase in age. However, data shows that urinary Na
+
 values in subjects with 
appropriate urine volumes decreases with an increase in age independent of gender and hypertensive 
status. Figure 3.7 summarises the results of stepwise regression analysis for relationships between 
upper limits and lower limits of salt intake versus blood pressure in participants when categorised 
into different age groups. The figure shows the relationships between age and systolic and diastolic 
BP i.e. 24-hour ABP, daytime ABP, night time ABP, conventional BP. 
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Figure 3.7: Upper limits and lower limits of salt intake versus age and blood pressure i.e 
SBP24; DBP24; DBPN; SBPN; SBPD;DBPN. 
DBP24 vs AGE
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CHAPTER FOUR 
 
DISCUSSION 
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A number of studies have reported on the relationship between salt intake and blood pressure, 
however these results are contradictory. Some show a positive relationship between BP and sodium 
while others have shown no association. The reason for these discrepancies could be methodological 
problems arising due to the daily variations in sodium intake. This raises a question whether the 24-
hour urine collection is a true representation of daily sodium intake. Hence in this study I first 
validate the 24-hour urine collection method before looking at the relationship between BP and 24-
hour urine sodium and potassium excretion. 
  
4.1 Validation of the 24-hour urine collection method  
Previous studies have used the 24-hour urine collection method to quantify the levels on dietary Na
+
 
intake (Ortega et al. 2010; Mente et al. 2014; Rhee et al. 2014; Michel et al 2014; Zhang et al. 2013; 
Scott et al 2011; Ji et al.2012; Millen et al 2013; Maseko et al. 2006). However, none of these 
studies have validated the 24-hour urinary excretion method. To my knowledge, other than a study 
conducted by Liu et al (1979) in a group of school children, there are no studies or data available 
regarding the use of the 24-hour urine collection method for prolonged periods of at least seven days 
in this population or any other adult population to check whether the levels of estimates of Na
+
 
intake can be reproducible over several consecutive days. In the above mentioned studies (Michel et 
al. 2014; Scott et al 2011; Millen et al 2013) there were weak or no relationships between Na
+
 intake 
and BP. It is uncertain whether this is a true reflection because there could be daily variations in Na
+
 
and K
+
 intake.  
In order to credibly draw a solid assumption of the relationship between Na
+
 intake and BP  in a 
population of African Ancestry, I assessed if a once-off 24-hour urine sample closely approximates 
daily Na
+
 intake over six consecutive days (methods described in Chapter 2). On analysis, I 
compared the levels of Na
+
 and K
+
 excretion between a 24-hour urine sample collected on the first 
day and the subsequent six days collection, and thereafter I compared the two methods. 
60 
 
Our data revealed that there was no major difference in Na
+
 and K
+
 intake from one day to the next. 
For Na
+
 intake, the average daily variation in the group was 3.2 mmol, and for K
+
 the average daily 
variation in intake was 2.1 mmol. Even where the sum of the consecutive six days collection was 
averaged (6 days average Na
+
 = 113.1 mmol; 6 days average K
+
 = 27.8 mmol), it did not vary 
significantly from the first day of urine collection (109.2 mmol Na
+
; 29.8 mmol K
+
). When testing 
for deviations for individual levels of daily Na
+
 excretion, data revealed that there was little variation 
in Na
+
 intake for each individual on a day-to-day basis; this was consistent to the report by Liu et al 
(1979). Although conducted for seven consecutive days and individuals had a relatively stable Na
+
 
intake, his results (Liu et al .1979) cannot be a representative of a population because it was 
conducted in a group of school children, contrary to my study where participants were randomly 
recruited. I then compared dietary sodium intake on the weekend with the other days of the week. 
Hypothetically, based on the social lifestyle of this community, it would have been expected that 
urinary excretion of the ions in question (Na
+
 and K
+
) would have been higher on days falling on the 
weekend, particularly Na
+
. The reason being that majority of this community attends social 
gatherings on weekends where they feast on different type of foods. However, our data showed that 
the levels of urinary excretions of Na
+
 and K
+
 were similar throughout the week.  
 
To further confirm that a single 24-hour urine collection sample closely approximates urine samples 
collected over a period of six subsequent days, I used the Bland-Augment plot to compare the two 
methods i.e. one day 24-hour urine collection versus six subsequent days 24-hour urine collection. 
The Bland-Augment plot yielded a clinically insignificant low bias (discrepancy) of -2.4. This 
further proved that the two methods are similar. Based on the above evidence it can be concluded 
that the use of a single 24-hour urine sample provides as accurate estimate of dietary Na
+
 intake in a 
population of African ancestry.   
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4.2 Relationship between urinary Na
+
 excretions and conventional blood pressure 
Sodium intake is a modifiable factor that has previously been reported to increase BP (Stocker et al. 
2010; Hajjar et al. 2001; Farquhar et al. 2015; Reddy et al. 2015; Zhang et al. 2013; du Cailar et al.  
2004; Rhee et al. 2014; Karppanen and Mervaala, 2006; Buyck et al. 2009). Having confirmed that 
Na
+
 excretions rates vary little from day-to-day in this population, I then analysed the relationship 
between Na
+
 intake and conventional blood pressure. In the present study of a randomly selected 
community sample of African ancestry, there was no independent relationship between Na
+
 intake 
and conventional SBP (P=0.47 and conventional DBP (P=0.84) after adjustments for confounding 
factors. The diffident relationship between Na
+
 intake and BP in the group is consistent with reports 
from previous large epidemiological studies including the Intersalt, the Scottish Heart Study 
(Intersalt Cooperative Research Group, 1988; Smith et al. 1988) and other epidemiological studies in 
populations of Africa ancestry (Hoosen et al. 1985; Charlton et al. 2005). This is indeed in disparity 
to a number of studies which show relationships between an index of Na
+
 intake with both SBP and 
DBP (O’Donnel et al, 2014).  
 
However I could not draw a conclusion that there is no relationship between BP and dietary Na
+
 
based on the conventional BP measurement because using the conventional BP technique to measure 
BP has a number of limitations. Conventional BP does not account for the circadian rhythms 
characterized by daytime and night-time BP or the overestimation of BP in people with white coat 
hypertension. Furthermore conventional BP readings are dependent on the observer therefore I could 
have overestimated BP values. This is confirmed by the clinically significant difference between the 
conventional BP (131mmHg/72mmHg) and ambulatory BP (118mmHg/72mmHg) of this 
population. It was therefore important that I look at the relationship between ambulatory BP and Na
+
 
before coming to any conclusion.  
 
62 
 
4.3 Relationship between dietary sodium and ambulatory blood pressure 
A stepwise multi regression analysis showed that there is no independent relationship between ABP 
measurements with Na
+
, regardless if it was 24-hour SBP (P=0.17), DBP (P=0.59); daytime SBP 
(P=0.15), DBP (P=0.68); or night-time SBP (P=0.69), DBP (P=0.25). The findings of the present 
study are consistent with studies done in other population groups (Shin et al. 2014; Staessen et al. 
1993). However in these studies they were able to show a positive correlation between night-time BP 
and Na
+
 excretion. Because Na
+
 is not excreted at the same rate throughout the day, it appears that 
overnight excretion rate is more positively associated with night time SBP (partial r = 0.29). The 
explanation to this relationship is understood to be the pressure natriuresis mechanism. Blood 
pressure is normally low at night compared to daytime. However, if Na
+
 is retained during the day, 
as in the case of people of African ancestry (Hall, 1990; Palacios et al. 2004; Harshfield, 2009; 
Dusta, 1989; Frisancho et al. 1984; Dressler, 1990), it may be excreted more during the night by 
elevating night-time BP levels to encourage the pressure-natriuresis mechanism and this results in 
non-dipping. That is why individuals who have a tendency to retain Na
+
, and those who are salt 
sensitive are generally non-dippers. In our population sample nocturnal BP dipping is less than 10%. 
This indicates that nocturnal BP dipping is attenuated. It is therefore possible that in our population 
sample night-time Na
+
 excretion is favored as indicated by the reduced BP dipping at night. 
Therefore the differences observed between our studies and these studies is that we did not separated 
daytime urine from nighttime urine samples. In future studies night time urine will be collected 
separately from daytime in order to establish if there is an independent relationship between dietary 
sodium and night-time BP in this population. Other factors that could account for the differences in 
our study with regard to the relationship between BP and dietary Na
+
 owing to the differences in 
composition of the study groups pertaining to age, gender, and race.  
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4.4 The impact of age on BP and Na
+
 excretion. 
In our population sample we observed a positive relationship between age and BP. This is consistent 
with many other studies that have been conducted in the past. Interestingly we observed a negative 
association between age and urinary Na
+ 
excretion (P≤0.001). The possible explanation is that age is 
a biological progression associated with structural adjustments in body organs and a decline in 
physiological functions (Gamici et al. 2009). Earlier studies have observed that, as with many other 
organs, there are structural changes that occur in the kidneys such as the reduction in the number of 
functional nephrons accompanied with progressive glomerulosclerosis which ultimately influences 
the kidney’s ability to excrete Na+, all of which are associated with the process of aging (Luft et al. 
1980; Kasiske, 1987; Berglund, 1983; Meneton et al. 2005). Expectedly, due to the decline in 
physiological functions associated with age, levels of urinary Na
+
 were predicted to decrease with an 
increase in age based on the understanding that human kidneys typically have a weakened ability to 
excrete Na
+
 (Luft et al. 1980; Kasiske, 1987; Berglund, 1983; Meneton et al. 2005). To my 
knowledge, this is the first study in this population to show that as age progresses, there is a fall in 
urinary Na
+
 excretion. The finding of the present study is supported by reports that there is a 
hastening fall in glomerular filtration rate (GRF) associated with age, and this fall begins around the 
ages of 30 years (Mimran and Ristein, 1992), as described, the average age of this population was 
well above 30 years age (43.9 years). Although there is a noticeable decline in urinary Na
+
 excretion 
with an increase in age, this does not necessarily suggest that there is a decline in Na
+
 consumption 
in the elderly group of this population.  It simply explains the heightened capacity to retain Na
+
 in 
the kidneys of the elderly as explained (Luft et al. 1980; Kasiske, 1987; Mimran and Ristein, 1992; 
Berglund, 1983; Meneton et al. 2005). It was also demonstrated (Luft et al. 1980) that after sodium 
load, normal subjects over the age 40 years excrete less sodium than those under 40 years.  
 
64 
 
With the understanding of the impact of age on N
+ 
excretion, we divided our population into age 
groups to assess the impact of Na
+ 
on age related increases in 24-hour, daytime and night-time BP 
for both systolic and diastolic BP. After adjusting for covariates, there was no difference in BP 
between participants whose daily salt intake was above the daily threshold and those whose salt 
intake was within the normal range across the adult life span. This further confirmed our findings 
that neither conventional nor ambulatory BP are associated with salt intake in black South Africans 
and supports the body of knowledge which shows no relationship between dietary Na
+
 intake and 
blood pressure. 
 
4.5. Relationship between the sodium-to-potassium ratio and blood pressure. 
Although my study shows no relationship between Na
+
 and BP, there is enough body of knowledge 
that supports the positive association between Na
+ 
that cannot be ignored. I then hypothesised that 
since Na
+ 
does not exist in isolation in body fluids but constantly interacts with other ions; its relation 
to blood pressure may not be independent of other body electrolytes in this population. We then 
focused on the sodium-to-potassium ratio (Na
+
/K
+
) and investigated its relationship to BP 
independent of other confounders.  There are studies conducted in other population groups that have 
provided evidence to suggests that the ratio of Na
+
/K
+
 could be responsible for BP regulation 
(Alderman, 2002), and an imbalance in this ratio; as in the case of high levels of Na
+
 and low levels 
of K
+
 intake could be associated with high BP and a greater risk for CVD (Zhang et al. 2013). In 
previous discussions, we have provided suggestions which propose mechanisms responsible for an 
increased BP in groups of African Ancestry. However, some studies suggest that the mechanisms 
involved are much more complex and other multiple interconnected factors such as increase in K
+
 
intake may improve BP (Adregue and Madias, 2014).  
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Before looking at the relationship between BP and Na
+
/K
+
,
 
I first assessed the association between 
BP and K
+
 in this population. I investigated whether daily K
+
 intake determined from 24-hour urine 
collection is associated with BP. Although the patterns of dietary K
+
 intake were previously explored 
in this urban, developing community of SOWETO (Maseko et al. 2006), I also investigated daily 
potassium intake in this population and my findings are consistent with data provided (Maseko et al. 
2006), which specifies that persons living in urban, developing community of SOWETO have 24-
hour urinary K
+
 excretion rates of 28.9 mmol/day which are less than the RDA of 120 mmol/day. 
However it should be mentioned that when dietary K
+
 is assessed from 24-hour urine excretion, it 
can be underestimated because unlike Na
+
, a considerable amount of the total K
+
 intake is excreted 
through defecation instead of micturition, and people of African Ancestry have low urinary K
+
 
excretion as compared to whites even when fed the same diet (Turban et al. 2008); further stressing 
that the lower urinary K
+
 excretion observed in groups of African Ancestry may reflect more than 
differences in intake. Also, the ratio of fecal to urinary K
+
 is said to be higher in groups of African 
Ancestry (Turban et al. 2008; Barlow et al. 1986; Voors et al. 1983). Even with the evidence that 
urinary K
+
 could be reduced by one-third as described in earlier studies (Barlow et al. 1986), 
participants would have potassium intake below the RDA of 120 mmol/day, even if that one-third 
was to be added to the recorded values.  
 
In the present study, our findings indicate that there is an association between urinary Na
+
/K
+
 ratio 
with 24-hour SBP (P=0.0004); daytime SBP ((P=0.001); night-time SBP (P=0.001); conventional 
SBP (P=0.0001). However, neither 24-hour urinary Na
+
 nor K
+ 
excretion alone was associated with 
BP, but the interaction of Na
+
/K
+
 influenced BP. This data is consistent with earlier studies which 
showed an association between urinary Na
+
/K
+
 ratio and BP (Intersalt Cooperative Research Group, 
1988, Smith et al. 1988). Outcomes described by the decrease in urinary K
+
 excretion on a high Na
+
 
diet in salt-sensitive individuals (Price et al. 2002; Scott et al. 2011).  
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The diminished urinary K
+
 excretion may be a result of a heightened activity of the Na-K-2Cl co-
transporter in the ascending limb of the renal tubule, hence Na
+
 excretion is somewhat associated 
with an increased BP in individuals with a decreased K
+
 excretion demonstrating the presence of an 
active Na-K-2Cl co-transporter in response to Na
+
 intake (Aviv et al. 2004). Additionally, diets 
containing excessive amounts of Na
+
 generally have a low K
+
 content, an effect that may also be 
reflected in higher urinary Na
+
/K
+
 values. Although previously reported that dietary K
+
 is associated 
with a decrease in BP (Alderman, 2002; Adregue and Madias, 2014; Houston, 2011; Geleijnse et al. 
2003; Appel, 2009) findings of the present study are less consistent with this data; no associations 
were observed between the index of K
+
 intake alone with indices of BP.  
 
The probable explanation concerning the discrepancies in these reports could either be that K
+
 
absorption in the gastrointestinal tract is reduced as seen in similar populations of African Ancestry 
(Turban et al. 2008) or that indeed this population living in SOWETO consumes less K
+
 containing 
foods (Maseko et al. 2006), therefore the lack of relations could be that K
+
 may have been too low to 
identify any meaningful
 
effect in a similar manner observed in other studies (Smith et al. 1985). 
These findings further support previous studies (Krishna et al. 1989; Morris et al. 1999)  backing that 
a mutual effect of dietary Na
+
 and K
+
 is greater than either alone in BP. It also appears that a 
diminished effectiveness of K
+
 in lowering BP is observed even when accompanied by a low Na
+
 as 
seen in larger trials such as the DASH study. Since this population has an attenuated night-time BP 
(Maseko et al. 2011; Maseko et al. 2013), and a relatively low K
+
 intake as estimated from urinary 
K
+
 excretion, the non-dipping BP status could be credited to low levels of K
+
. Findings of the present 
study with regards to the importance of the Na
+
/K
+
 ratio instead of either alone in regulating BP is 
strongly supported by outcomes (Wilson et al. 1999; Krishna et al. 1989; Weinberger et al. 1982) 
which propose that changes in dietary K
+
 alter Na
+
 balance, wherein K
+
 restriction leads to Na
+
 
retention, whereas K
+
 supplementation offers a greater natriuresis.  
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Notably, data from the present study revealed associations between Na
+
/K
+
 ratio only with systolic 
ABP measurements (24-hour SBP, daytime SBP, night-time SBP) but no relations with any diastolic 
pressures. Similarly, these relations were observed for Na
+
/ K
+
 ratio with conventional BP 
measurement. The lack of relations between Na
+
/K
+
 ratio and diastolic pressures in this population 
could be explained based on findings previously noted in our group were the relationship between 
urinary Na
+
/K
+
 and BP were stronger for PP than DBP (Redelinghuys et al. 2010), consistent with 
findings (Sesso et al. 2000) that SBP and PP are more associated with an increased BP, an incidence 
of CVD and that when considering SBP, DBP, MAP, and PP, both MAP and DBP lose a predictive 
value for HT and CVD in general as people age (Sesso et al. 2000).  
 
4.6 Renin activity and salt sensitivity. 
The decline in Na
+
 excretion discussed previously appears not be an issue only in the elderly, 
however this overall deterioration in GRF is more marked in people of African ancestry (Mimran 
and Ristein, 1992; Meneton et al. 2005). Previous studies have demonstrated that Na
+
 retention is a 
problem in populations of African Ancestry (Hall, 1990; Palacios et al. 2004; Harshfield, 2009; 
Dusta, 1989; Frisancho et al. 1984; Dressler, 1990). Additionally, existing evidence on clinical and 
experimental studies have shown that people of African Ancestry, having a higher Na
+
 retention also 
have increased BP (Luft et al. 1982).  
 
There is now extensive evidence to suggest that Na
+
 retention in populations of African Ancestry is a 
major pathophysiological mechanism responsible for an elevated BP, it also appears that the very 
same mechanism has been proposed to cause a suppression of renin and aldosterone secretion (Price 
and Fisher, 2003). Considering the average low levels of renin in the present study (37.4±77.9), it is 
consistent with a large body of evidence which reports that people of African Ancestry are 
classically considered a “low renin” race (Chrysant et al. 1979; Rayner and Ramesar, 2015; Rayner 
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et al. 2001; Sagnella, 2001; Williams et al. 2014; Wali and Wei, 1999; Campese, 1996; Aksut and 
Karimkhani, 2014; Kola et al. 2009).  
 
Initially exposed by Helmer and Judson (1968) that people of African origin generally have low 
renin as compared to whites, it is now widely accepted through numerous literatures (Chrysant et al. 
1979; Rayner and Ramesar, 2015; Rayner et al. 2001; Sagnella, 2001; Williams et al. 2014; Wali and 
Wei, 1999; Campese, 1996; Aksut and Karimkhani, 2014; Kola et al. 2009). Although in the present 
study of a population of African ancestry we did not compare levels of renin between races, we still 
observed low renin levels (37.4±77.9). This observation of low renin activity in this population of 
African Ancestry is supported by assertions from previous studies in this particular population (Scott 
et al. 2011; Michel et al. 2012). Moreover, our analysis showed that decreasing tertials of renin were 
associated with an increase in BP. Furthermore, this association is characteristic between 
normotensives and hypertensives in the group, an observation in keeping with earlier studies (Mitas 
et al. 1979; Leary and Asmal, 1975). The low-renin high-BP relationship in the present study attests 
that our study population like population of African ancestry is “salt sensitive”.   
 
High-Na
+
, low-K
+
 diets suppress renin release in salt sensitive individuals (Fisher et al. 1999). Thus, 
these findings further suggest that the decrease in renin and heightened Na
+
 retention may indeed 
play a significant part in promoting Na
+
 effects on BP in salt sensitive individuals. Therefore, the low 
renin observed in the present study explains the prevalence of increased BP in this population. 
Certainly, with more unanimity now than previously, research suggest that the low renin may be 
ascribed to genetic variation across racial lines (Sagnella, 2001). Indeed, though not investigated in 
the present study because it was previously studied in our group (Tiago et al. 2002; Woodiwiss et al. 
2006). The low renin levels are attributed to genetic influences.  
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These influences are demonstrated to occur in salt sensitive populations and may be triggered by Na
+
 
effects on interactions with specific genes in groups of African Ancestry, and these connections are 
consistent with results reported in other populations of African Ancestry (Campese, 1996; Brewster 
and Seedat, 2013). These interactions indicate that Na
+
 sensitivity is similarly established in 
normotensives and hypertensives of African Ancestry, data that is supported by findings in earlier 
studies (Sowers et al. 1988), further proposing common genetic determinants in groups of African 
Ancestry. The present study has indicated that BP increases with low levels of renin, and the findings 
may suggest that the association between renin concentration and BP could possibly involve an 
interaction between BP and Na
+
 intake, however the relationship between BP and Na
+
 in this 
population remains controversial and further research is required in this regard. 
 
4.7 Sodium intake and arterial stiffness 
Even though Na
+
 I could not show any relationship between dietary Na
+
 intake and BP, sodium 
could increase BP indirectly by increasing arterial stiffness. I therefore analyzed the association 
between Na
+
 intake and PWV (an index of arterial stiffness). After adjusting for covariates 
(including age) there was a strong relationship between PWV and Na
+
 intake (P=0.002). This finding 
is supported by a report which has demonstrated that dietary Na
+
 together with an increase in age 
amplifies stiffness of blood vessels, and that low-sodium diet in older adults improves arterial 
compliance (Zieman et al. 2005). The proposed mechanism relating the increase in PWV and age 
which are both associated with a decrease in urinary Na
+
 excretion in the group is that; age is 
accompanied with structural changes mainly in the medial layer of the arteries and this promotes 
arterial stiffening (an increase in PWV), consequently this affects the target organ (kidneys) because 
of its effect on pressure and flow pulsitility (Jain et al. 2014; Zieman et al. 2005).  
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The inability to excrete Na
+
 as people age is an overall resultant effect of this mechanism coupled 
with the structural changes that occur within the kidney itself. Therefore in this population, Na
+
 is 
directly related to arterial stiffness independent of age. Since arterial stiffness is strongly associated 
with BP; it is possible that associations between Na
+ 
and BP are strongly influenced by arterial 
stiffness.   
 
4.8 Conclusion 
In conclusion, the present study has demonstrated that in a random recruited urban community 
sample of African ancestry, the use of a single 24-hour urine sample provides as accurate an estimate 
of dietary Na
+
 and K
+
 as that estimated from a longer period of urine collection, therefore a single 
24-hour urine measurement is sufficient to estimate the levels of Na
+
 intake. Also, in this community 
of African ancestry, Na
+
 and K
+
 intake could not be predicted to be higher on certain days of the 
week and did not depend on which day of the week the urinary Na
+
 excretion measurement was 
taken. Although high Na
+
 intake and low K
+
 intake (indexed by 24-hour urine electrolyte excretion 
rates) characterises this community, none of these factors alone is associated with conventional and 
ambulatory BP measurements. Even when we considered the effects of age on 24-hour excretion and 
divided the population according to age groups, there was no significant difference in BP between 
people whose sodium consumption was above the threshold of 100mmol/day and those whose 
sodium consumption was within normal range. Interestingly the Na
+
/K
+
 was associated with BP 
indicating that this ratio is more important in regulating BP in this population than either K
+ 
or Na
+ 
alone. This means in this population, advocating for a low sodium diet is not sufficient, but 
consumption of fruits and vegetables which are rich in potassium should be promoted. This could 
lead to the effective control of BP in this community easing the burden of patient care on the 
resource limited health care system.  
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4.7 Possible study limitations and future perspective  
It should be mentioned that in the present study a number of potential limitations were noted and 
resolutions to these limitations were modelled. As with a number of research studies of this nature, 
studies where participants are randomly recruited, more women than men participate as is the case in 
the present study, this is mainly due to that women in settings of urban communities in South Africa 
are usually available and as compared to men most of them are not employed. Also, men have a 
negative perception and stigmatisation with issues pertaining to human medical research while 
women often view participation as means of free medical screening. However, the imbalance in 
number of males and females could demonstrate bias in the data. None the less, gender was included 
as a covariate in regression analysis. Often times, age does influence outcomes in research studies, 
hence it in the present study it was important that age be included in the regression analysis and its 
effects be studied in different groups. The present study was cross-sectional, hence I did not make 
interventions to participant’s dietary patterns with regards to Na+ and K+ intake. Therefore future 
studies in this population group should focus on dietary interventions such as reductions in Na
+ 
intake and increased K
+
 intake to observe if dietary changes could play a role in decreasing BP 
particularly in this population as reported in other studies (Geleijnse et al. 2003; Appel, 2009; 
Drenjancevic-Peric et al. 2011; Gu et al. 2008; He and MacGregor, 2010). Although in the present 
study it was demonstrated that there is little variation of Na
+
 and K
+
 intake from day to day, future 
studies should also investigate whether spot urine can reproduce the same results as that obtained 
from 24-hour urine collection in this population. Future studies should also separate daytime urine 
from night-time urine sample to study the effects of each on BP independently.  
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